Top

Published in:

01-12-2011 | Original Paper

Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents

Authors: Elif Kaya, Alessandro Cuneo, Matthias Hochadel, Claus Jünger, Wibke Stepper, Peter Bramlage, Karl-Heinz Kuck, Christoph A. Nienaber, Jochen Senges, Lars Eckardt, Ulrich Tebbe, Holger Reinecke

Published in: Clinical Research in Cardiology | Issue 12/2011

Abstract

Background

Chronic kidney disease (CKD) has an adverse impact on survival of patients with coronary artery disease and is associated with poor outcomes after percutaneous coronary intervention (PCI). Although small randomized, controlled clinical trials showed a reduced target vessel revascularization rate and a good safety profile for sirolimus-eluting coronary stents (SES), safety data need to be confirmed in clinical practice. Therefore, the data of the German DES.DE registry were evaluated to obtain acute and long-term data of this high-risk subgroup.

Methods

The prospective multicenter German DES.DE registry enables to monitor the therapeutic outcome of different drug-eluting stents in the context of the German Health Care System. Baseline clinical and angiographic characteristics as well as one-year-follow-up data were recorded. From October 2005 to October 2006, 6,384 patients were enrolled at 98 DES.DE sites and stratified according to kidney disease progression: normal and impaired renal function and patients under chronic hemodialysis.

Results

CKD was associated with several acute and chronic medical conditions and suffer from significantly more cardiac and cerebrovascular events after PCI as compared to patients without CKD. One-year-follow-up showed a significantly increased risk of restenosis and bleeding complications in patients with impaired renal function, especially in hemodialysis patients.

Conclusions

Impaired renal function in patients undergoing DES stenting carries an independent risk factor for restenosis and bleeding.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef

Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM (2003) Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 63:696–701PubMedCrossRef

Muntner P, He J, Hamm L, Loria C, Whelton PK (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13:745–753PubMed

Lemos PA, Arampatzis CA, Hove A et al (2005) Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 95:167–172PubMedCrossRef

Kuchulakanti PK, Torguson R, Chu WW et al (2006) Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutanous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 97:792–797PubMedCrossRef

Nienaber CA, Akin I, Schneider S et al (2009) Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare-metal stents in a real world setting (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 104:1362–1369PubMedCrossRef

Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356:147–152PubMedCrossRef

Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr (2003) Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14:2373–2380PubMedCrossRef

Reddan DN, Marcus RJ, Owen WF Jr, Szczech LA, Landwehr DM (2001) Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 38:57–63PubMedCrossRef

10.

Herzog CA, Ma JZ, Collins AJ (2002) Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106:2207–2211PubMedCrossRef

11.

Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA (2003) Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92:509–514PubMedCrossRef

12.

Yachi S, Tanabe K, Tanimoto S et al (2009) Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 54:299–306PubMedCrossRef

13.

Syed AI, Ben-Dor I, Collins SD et al (2010) Sirolimus-eluting stent versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J Inter Cardiol 23:33–39CrossRef

14.

Jeong YH, Hong MK, Lee CW et al (2008) Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 125:36–40PubMedCrossRef

15.

Best PJ, Berger PB, Davis BR et al (2004) Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol 44:1786–1791PubMed

16.

Blackman DJ, Pinto R, Ross JR et al (2006) Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 151:146–152PubMedCrossRef

17.

Halkin A, Mehran R, Casey CW et al (2005) Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 150:1163–1170PubMedCrossRef

18.

Ota T, Umeda H, Yokota S et al (2009) Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J 158:92–98PubMedCrossRef

19.

Morice MC, Serruys PW, Sousa JE et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRef

20.

Degertekin M, Serruys PW, Foley DP et al (2002) Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 106:1610–1613PubMedCrossRef

21.

Lee MS, Canan T, Perlowski A, Bhatia R, Jurewitz D, Tobis JM (2009) Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting. J Invasive Cardiol 21:41–445

22.

Reinecke H, Brand E, Mesters R et al (2009) Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 20:705–711PubMedCrossRef

23.

Appleby CE, Ivanov J, Lavi S et al (2009) The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Circ Cardiovasc Interv 2(4):309–316PubMedCrossRef

24.

Latif F, Kleiman NS, Cohen DJ et al (2009) In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. J Am Coll Cardiol Cardiovasc Interv 2:37–45

25.

Tsai TT, Maddox TM, Roe MT et al (2009) Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 302:2458–2464PubMedCrossRef

Title: Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents
Authors: Elif Kaya
Alessandro Cuneo
Matthias Hochadel
Claus Jünger
Wibke Stepper
Peter Bramlage
Karl-Heinz Kuck
Christoph A. Nienaber
Jochen Senges
Lars Eckardt
Ulrich Tebbe
Holger Reinecke
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Clinical Research in Cardiology / Issue 12/2011
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-011-0347-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2011

Severe dyspnoea during late pregnancy in a woman with history of asthma

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?

Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy

Sympatho-renal axis in chronic disease

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction

A rare association of long QT syndrome and syndactyly: Timothy Syndrome (LQT 8)